This topic contains a solution. Click here to go to the answer

Author Question: When a market may require a drastically simplified version of the firm's product due to lack of ... (Read 101 times)

ericka1

  • Hero Member
  • *****
  • Posts: 544
When a market may require a drastically simplified version of the firm's product due to lack of purchasing power or usage conditions, this is known as:
 a. supplementing.
  b. backward innovation.
  c. backward integration.
  d. forward integration.

Question 2

Which of the following is not one of the factors that drive global sourcing performance?
 a. Centrally coordinated and centrally led decision making.
  b. Site-based control of operational activities.
 c. Ability to speak multiple foreign languages.
 d. Sourcing and contracting systems.
 e. International purchasing office support.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

momo1250

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

B

Answer to Question 2

c




ericka1

  • Member
  • Posts: 544
Reply 2 on: Jun 29, 2018
YES! Correct, THANKS for helping me on my review


cassie_ragen

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The B-complex vitamins and vitamin C are not stored in the body and must be replaced each day.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library